Literature DB >> 1598988

Grading system for the selection of patients with congenital aural atresia.

R A Jahrsdoerfer1, J W Yeakley, E A Aguilar, R R Cole, L C Gray.   

Abstract

It is generally recognized that surgery for congenital aural atresia is difficult. In an effort to select those patients who have the greatest chance of success, we have developed a grading scheme based on the preoperative temporal bone CT scan and the appearance of the external ear. Patients are graded on a possible best score of 10. The stapes is assigned the highest rating (2 points), while all other entrees on the scale are 1 point. The grade assigned preoperatively has been shown to correlate well with the patient's chance of success, herein defined as a postoperative speech reception threshold of 15 to 25 dB. A patient with a preoperative grade of 8/10 would, therefore, have a 80 percent chance of achieving this threshold. Patients with scores of 5/10, or less, are not considered surgical candidates, because the risk of the operation would outweigh the potential benefits. We have found that the grading system allows us to avoid impossible surgical cases while allowing for a reasonable prediction of the hearing outcome.

Entities:  

Mesh:

Year:  1992        PMID: 1598988

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  32 in total

1.  Reconstructive methods in hearing disorders - surgical methods.

Authors:  Thomas Zahnert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

2.  [New surgical techniques for the treatment of auricular atresia].

Authors:  R Siegert
Journal:  HNO       Date:  2004-03       Impact factor: 1.284

3.  Audiological effectiveness of Bonebridge implantation for bilateral congenital malformation of the external and middle ear.

Authors:  Ran Ren; Shouqin Zhao; Danni Wang; Yi Li; Xiaobo Ma; Yuling Li; Xinxing Fu; Peiwei Chen; Jingmin Dou
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-02       Impact factor: 2.503

Review 4.  Syndromes of the first and second branchial arches, part 1: embryology and characteristic defects.

Authors:  J M Johnson; G Moonis; G E Green; R Carmody; H N Burbank
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

5.  Prognostic factors for long-term hearing preservation after canal-tympanoplasty for congenital aural atresia.

Authors:  Takashi Sakamoto; Shu Kikuta; Yayoi S Kikkawa; Makoto Kinoshita; Yuki Saito; Kenya Kobayashi; Akinobu Kakigi; Mitsuya Suzuki; Tatsuya Yamasoba
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-17       Impact factor: 2.503

6.  Minimal Reporting Standards for Active Middle Ear Hearing Implants.

Authors:  Hannes Maier; Uwe Baumann; Wolf-Dieter Baumgartner; Dirk Beutner; Marco D Caversaccio; Thomas Keintzel; Martin Kompis; Thomas Lenarz; Astrid Magele; Torsten Mewes; Alexander Müller; Tobias Rader; Torsten Rahne; Sebastian P Schraven; Burkard Schwab; Georg Mathias Sprinzl; Bernd Strauchmann; Ingo Todt; Thomas Wesarg; Barbara Wollenberg; Stefan K Plontke
Journal:  Audiol Neurootol       Date:  2018-09-07       Impact factor: 1.854

7.  Otologic and audiology aspects of microtia repair.

Authors:  Michael J Lipan; Adrien A Eshraghi
Journal:  Semin Plast Surg       Date:  2011-11       Impact factor: 2.314

8.  High-resolution CT findings in children with a normal pinna or grade I microtia and unilateral mild stenosis of the external auditory canal.

Authors:  R Jacob; S Gupta; B Isaacson; J W Kutz; P Roland; Y Xi; T N Booth
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-14       Impact factor: 3.825

9.  Semiautomated Middle Ear Volume Measurement as a Predictor of Postsurgical Outcomes for Congenital Aural Atresia.

Authors:  S J Kabadi; D S Ruhl; S Mukherjee; B W Kesser
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

10.  The "boomerang" malleus-incus complex in congenital aural atresia.

Authors:  S Mukherjee; B W Kesser; P Raghavan
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.